$5.10
0.04 (+0.69%)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)
CAPS Rating:
A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.
RSS Headlines
Fool UK